The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms......
'Its efficacy is 97.6 per cent.' Morepen India Chairman and Managing Director Sushil Suri in an interview with Uddalok Bhattacharya says the Sputnik V vaccine it is manufacturing in India......
The Russian Direct Investment Fund (RDIF) has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India, which has also given approval for the emergency......
‘We expect to get the approval in the next few weeks,’ says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL). IMAGE: Medics administer the first......
Pharma companies are scouting for customers to sell the waste products, including solvents and pigments, generated in their companies. These products are used as raw materials in other industries,......
Even as the substitutability of biogeneric or biosimilar medicines with their original patented counterparts continues to be a matter of debate world over, Indian drug companies, which have......
Ranbaxy Laboratories, Dr Reddy's Laboratories, Nicholas Piramal and other pharmaceutical companies are betting on inlicensing or strategic marketing tie-ups to help grow local sales after India......
Close on the heels of allegations that India's weak patent laws deter big pharmaceutical companies of the West from investing in India, a study by a Swedish University has accused India's Active......
Chinese bulk drug suppliers have raised their prices steeply, taking a toll on the profit margins of Indian pharmaceutical companies. Indian companies had shut their own bulk drug plants to take......